期刊文献+

促凋亡蛋白Bid在肝癌发生过程中的作用 被引量:2

Influence of pro-apoptosis protein Bid on hepatocarcinogenesis
下载PDF
导出
摘要 目的探讨促凋亡蛋白Bid在肝癌发生中的作用。方法应用基因毒性药物二乙基亚硝胺(diethylnitrosamine,DEN)制备小鼠实验性肝癌动物模型,通过阻断(Bid缺陷小鼠)或诱导(抗Fas抗体注射)肝细胞凋亡过程,观察肝癌发生中Bid蛋白的作用。结果1.在致癌剂DEN和凋亡诱导剂抗Fas抗体注射小鼠后8个月,在野生型小鼠肝脏内瘤结节外周BrdU标记指数显著高于Bid缺陷的小鼠(P=0·016);2.野生型动物与Bid缺陷型动物比较,肝内瘤结节的个数、面积以及肝脏受累比率二者差异具有显著性(P值分别为0·025、0·002和0·004)。结论Bid缺陷小鼠对DEN诱导的肝癌具有明显的抵抗作用,这一作用可能与Bid的促增殖作用有关。 Objective To investigate how pro-apoptosis proteins Bid influence the development and progres of experimental liver cancer. Methods Mouse model was established by injection of 15 μg/g body weight careinogen-diethylnitrosamine (DEN), then blocked or induced cell apoptosis signal pathway by employing Bid knock-out mice (ko) or injecting anti-Fas antibody to detect the influence of Bid protein on the development and progression of hepatocarainogenesis. Results 1. There was a significant higher level BrdU labeling index outside tumorigenesis loci of wild type (wt) mice than that in knock out mice at 8 month after DEN exposure and anti-Fas antibody injection ( P =0.016). 2.The average number and area of tumorigenesis loci or nodules and percentage of liver area affected in wt mice were found much more than those in knock out mice ( P = 0.025, P = 0.002 and P = 0.004, respectively). Conclusion Bid knock out mice show an obvious resistant to hepatocarcinogenesis initiated by DEN exposure, which might be relevant to promote cell proliferation of Bid protein.
出处 《胃肠病学和肝病学杂志》 CAS 2006年第6期603-605,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 凋亡 细胞增殖 肝癌发生 二乙基亚硝胺 BID Apoptosis Cell proliferatiom Hepatocarcinogenesis Diethylnitrosamine Bid
  • 相关文献

参考文献12

  • 1Li S, Zhao Y, He X, et al. Belief of extrinsic pathway inhibition by the Bid-dependent Mitochondrial Release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem, 2002, 277(30):26912-26920.
  • 2Linette GP, Li Y, Both K, et al. Cross talk between cell death and cell cycle progression: Bcl-2 regulates NLAT-mediated activation. Proc Natl Acad Sci USA, 1996,93(18):9545-9552.
  • 3Vail ME, Chaisson ML, Thompson J, et al: Bcl-2 expression delays hepatocyte cell cycle progression during liver regeneration. Oneogene, 2002,21(10): 1548-1555.
  • 4Mazel S, Burtrum D, Petrie H. Regulation of cell division cycle progression by bcl-2 expression : a potential mechanism for inhibition of programmed cell death. J Exp Med, 1996, 183(15) :2219-2226.
  • 5O' Reilly LA, Huang DC, Strasser A, The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J, 1996, 15(24):6979-6990.
  • 6Knudson CM, Johnson GM, Lin Y. Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res, 2001,61 (2):659-665.
  • 7Chattopadhyay A, Chiang CW, Yang E. BAD/BCL-[X(L)] heterodimerization leads to bypass of GO/GI arrest. Oncogene, 2001,20(33): 4507-4518.
  • 8Mok CL, Gil Gomez G, Williams O, et al. Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med, 1999,189(3) :575-586.
  • 9Cheng N, Janumyan YM, Didion L, et al. Bcl-2 inhibition of T-cell proliferation is related to prolonged T-ceil survival. Oncogene, 2004,23 (21):3770-3780.
  • 10Janumyan YM, Sansam CG, Chattopadhyay A, et al. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J, 2003,22(2): 5459-5470.

同被引文献32

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部